tiprankstipranks
Advertisement
Advertisement

DE:RGO Stock Latest News

Regeneron price target raised to $779 from $765 at RBC Capital
The FlyRegeneron price target raised to $779 from $765 at RBC Capital
8h ago
REGN
Regeneron to invest up to $200M in TriNetX as part of strategic collaboration
PremiumThe Fly
Regeneron to invest up to $200M in TriNetX as part of strategic collaboration
5d ago
REGN
Regeneron announces FDA approval of extension of dosing intervals for EYLEA HD
PremiumThe Fly
Regeneron announces FDA approval of extension of dosing intervals for EYLEA HD
5d ago
REGN
Regeneron price target lowered to $801 from $818 at Truist
PremiumThe Fly
Regeneron price target lowered to $801 from $818 at Truist
7d ago
REGN
Regeneron assumed with an Overweight at Piper Sandler
PremiumThe Fly
Regeneron assumed with an Overweight at Piper Sandler
8d ago
REGN
Regeneron, Sanofi get approval for Dupixent to treat bullous pemphigoid in Japan
PremiumThe FlyRegeneron, Sanofi get approval for Dupixent to treat bullous pemphigoid in Japan
15d ago
SNY
REGN
Regeneron price target raised to $825 from $800 at Wells Fargo
Premium
The Fly
Regeneron price target raised to $825 from $800 at Wells Fargo
20d ago
REGN
Vertex Pharmaceuticals price target raised to $550 from $515 at Wells Fargo
Premium
The Fly
Vertex Pharmaceuticals price target raised to $550 from $515 at Wells Fargo
20d ago
AMGN
REGN
Amgen price target raised to $390 from $375 at Wells Fargo
PremiumThe Fly
Amgen price target raised to $390 from $375 at Wells Fargo
20d ago
AMGN
REGN
Regeneron says Hansoh shares topline data from Phase 3 trial of olatorepatide
PremiumThe Fly
Regeneron says Hansoh shares topline data from Phase 3 trial of olatorepatide
30d ago
REGN
Regeneron initiated with an Overweight at Barclays
PremiumThe Fly
Regeneron initiated with an Overweight at Barclays
1M ago
REGN
Regeneron price target raised to $765 from $745 at RBC Capital
PremiumThe Fly
Regeneron price target raised to $765 from $745 at RBC Capital
1M ago
SNY
REGN
Regeneron, Sanofi announces EMA for CHMP adopted positive opinion for Dupixent
PremiumThe FlyRegeneron, Sanofi announces EMA for CHMP adopted positive opinion for Dupixent
1M ago
SNY
REGN
Regeneron, Sanofi announce FDA approval of Dupixent for AFRS
Premium
The Fly
Regeneron, Sanofi announce FDA approval of Dupixent for AFRS
1M ago
SNY
REGN
Regeneron announces FDA accepted Priority Review for BLA for garetosmab
Premium
The Fly
Regeneron announces FDA accepted Priority Review for BLA for garetosmab
2M ago
REGN
Regeneron highlights expanding portfolio, pipeline at AAAI
PremiumThe Fly
Regeneron highlights expanding portfolio, pipeline at AAAI
2M ago
SNY
REGN
Regeneron price target raised to $975 from $865 at Guggenheim
PremiumThe Fly
Regeneron price target raised to $975 from $865 at Guggenheim
2M ago
REGN
Regeneron’s Expanding AI Use Raises Data Privacy, Regulatory and Market Risks
PremiumCompany Announcements
Regeneron’s Expanding AI Use Raises Data Privacy, Regulatory and Market Risks
2M ago
REGN
Regeneron price target raised to $800 from $740 at Cantor Fitzgerald
PremiumThe Fly
Regeneron price target raised to $800 from $740 at Cantor Fitzgerald
2M ago
REGN
Regeneron price target raised to $742 from $630 at Baird
PremiumThe FlyRegeneron price target raised to $742 from $630 at Baird
2M ago
REGN
Regeneron price target raised to $865 from $750 at Oppenheimer
Premium
The Fly
Regeneron price target raised to $865 from $750 at Oppenheimer
2M ago
REGN
Regeneron announces upcoming presentations at Angiogenesis annual meeting
Premium
The Fly
Regeneron announces upcoming presentations at Angiogenesis annual meeting
2M ago
REGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >